Sign in

CIK 0001652130

  • Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364785571
Phone
+1 857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 8-K Event Regulation FD disclosure · Other events
  2. 8-K Event Results of operations · Executive or director change
  3. 8-K Event Regulation FD disclosure · Other events
  4. 8-K Event Executive or director change · Shareholder vote results
  5. 8-K Event Regulation FD disclosure · Other events
  6. 8-K Event Regulation FD disclosure · Other events
  7. 8-K Event Results of operations
  8. 8-K Event Bylaws or fiscal year change
  9. 8-K Event Results of operations
  10. 8-K Event Material agreement · New debt or obligation
  11. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure · Other events
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Results of operations
  14. 8-K Event Regulation FD disclosure · Other events
  15. 8-K Event Results of operations
  16. 8-K Event Executive or director change · Regulation FD disclosure
  17. 8-K Event Executive or director change · Regulation FD disclosure
  18. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  19. 8-K Event Results of operations
  20. 8-K Event Executive or director change

Page 2 of 7 · 140 filings